<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although the blood-brain barrier effects of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> have been extensively examined, less attention has focused on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced damage to the choroid plexuses that form the blood-cerebrospinal fluid (CSF) barrier (BSCFB) </plain></SENT>
<SENT sid="1" pm="."><plain>This study examined the rat lateral ventricle choroid plexuses (LVCP) in three ischemic models, bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (2VO)+<z:hpo ids='HP_0002615'>hypotension</z:hpo> with or without reperfusion and permanent middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion with or without a tandem common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Blood flow was assessed using [(14)C]-N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p-iodoamphetamine, and LVCP injury by tissue <z:hpo ids='HP_0000969'>edema</z:hpo>, alterations in [(14)C]glutamine transport and BSCFB disruption (measured with [(3)H]<z:chebi fb="0" ids="15443">inulin</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>2VO+<z:hpo ids='HP_0002615'>hypotension</z:hpo> caused an 87% reduction in LVCP blood flow (P&lt;0.01) and a progressive reduction in LVCP glutamine transport </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to cortex, there was no LVCP hyperemia or delayed hypoperfusion on reperfusion, but there was marked BSCFB disruption </plain></SENT>
<SENT sid="5" pm="."><plain>After 30 mins of 2VO+<z:hpo ids='HP_0002615'>hypotension</z:hpo> with 6 h of reperfusion, the [(3)H]<z:chebi fb="0" ids="15443">inulin</z:chebi> entry into CSF was increased threefold (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Blood-CSF barrier rather than blood-brain barrier disruption appeared to be the main cause of enhanced [(3)H]<z:chebi fb="0" ids="15443">inulin</z:chebi> entry into hippocampus </plain></SENT>
<SENT sid="7" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> with and without a tandem common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> only caused 53% and 38% reductions in LVCP blood flow but induced LVCP <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Results suggest that the LVCP is selectively vulnerable to ischemic injury in terms of the absolute blood flows or, for the <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion models, the % reductions in flows required to induce injury </plain></SENT>
<SENT sid="9" pm="."><plain>BCSFB disruption early after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> may enhance the movement of compounds from blood to areas close to the ventricular system and participate in delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>